Dr Paschal McCloskey is the Engagement Manager at the Northern Ireland Connected Health Innovation Centre which delivers industry-led healthcare research in Northern Ireland.
He has recently been the CEO of a leading nanotechnology company which launched the world’s first MOF product along with raising £5M funding.
He has over 10 yrs experience in commercialising early stage University Technology in the Med Tech / Chemical sectors.
He has worked as an Investment Manager at a transatlantic Investment Firm with a focus in the healthcare and medical device sector. Previous to this he was responsible for commercialising new technologies from Queen’s University.